Physician

Abigail Mclaughlin

According to 2025 Medicare claims, Abigail Mclaughlin (NPI: 1417696105) practices nurse practitioner in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is ATLANTICARE HEALTH SERVICES INC. (NPI: 1043700495; TIN: 223265214) and primary practice location at 08225-9438.

Mclaughlin's data goes back to 2015 and runs through 2024. Part D data shows 1,102 prescription claims across 140 beneficiaries totaling $150,146 in drug costs, led by Ozempic (Semaglutide). Open Payments data shows 4 records totaling $167. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	75	235	$24,154
2023	144	772	$90,702
2024	140	1,102	$150,146

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	28	828	$26,958
Januvia	Sitagliptin Phosphate	24	1,260	$21,435
Jardiance	Empagliflozin	14	780	$13,895
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	52	1,072	$12,122
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	540	$11,887

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$167	Braeburn Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abigail Mclaughlin?

Tedicare shows public-source Medicare data for Abigail Mclaughlin (NPI 1417696105), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abigail Mclaughlin have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abigail Mclaughlin?

Abigail Mclaughlin is linked to ATLANTICARE HEALTH SERVICES INC. (billing NPI 1043700495) in the available physician profile data.

Does Abigail Mclaughlin have Open Payments data?

Abigail Mclaughlin has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.